首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

1619137

C 反應蛋白檢測市場規模、佔有率、成長分析、按檢測類型、按檢測範圍、按疾病領域、按最終用途、按地區 - 行業預測，2024-2031 年

C-Reactive Protein Testing Market Size, Share, Growth Analysis, By Assay Type (Immunoturbidimetric Assay, Elisa), By Detection Range (HS-CRP, Conventional CRP), By Disease Area, By End-Use, By Region - Industry Forecast 2024-2031

出版日期: 2024年12月18日 | 出版商:

SkyQuest | 英文 260 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022 年，C 反應蛋白檢測的全球市場規模為 45 億美元，從 2023 年的 46 億美元成長到 2031 年的 55.2 億美元，在預測期內（2024-2031 年）預計將以年複合成長率為2.3%。

在提高特異性、敏感性和快速現場疾病診斷的奈米技術進步的推動下，全球 C 反應蛋白檢測市場預計將顯著成長。為了滿足對快速診斷工具日益成長的需求，新的 CRP 檢測即時檢測方法不斷出現。穆罕默德六世大學的一項研究揭示了 CRP 在評估 SARS-CoV-2 嚴重程度方面的潛力，進一步提升了 CRP 的重要性。此外，發炎性疾病、糖尿病、癌症盛行率的上升、子宮內膜異位症盛行率的上升以及診斷資金的增加預計將推動市場擴張。 CDC 報告稱，美國有超過 2010 萬成年人患有冠狀動脈疾病，並且這一數字預計將繼續成長。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東/非洲
- 海灣合作理事會國家
- 南非
- 其他中東/非洲

競爭資訊

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市場趨勢
公司市場佔有率分析（2023）
主要企業簡介
- 公司簡介
- 產品系列分析
- 按細分市場分類的佔有率分析
- 收益與前一年同期比較（2021-2023）

主要企業簡介

Thermo Fisher Scientific Inc.
Roche Diagnostics
Abbott Laboratories
Beckman Coulter
Bio-Rad Laboratories
Siemens Healthcare
Quest Diagnostics
Ortho Clinical Diagnostics
Randox Laboratories
Boditech Med Inc.
Merck Millipore
BioMerieux
Trinity Biotech
Becton, Dickinson and Company（BD）
Sekisui Diagnostics
Tosoh Bioscience Inc.
DiaSorin SpA
Fujifilm Corporation

結論和建議

簡介目錄

Product Code: SQMIG35A2715

Global C-Reactive Protein Testing Market size was valued at USD 4.5 billion in 2022 and is poised to grow from USD 4.6 billion in 2023 to USD 5.52 billion by 2031, growing at a CAGR of 2.3% during the forecast period (2024-2031).

The global market for C-reactive protein testing is poised for significant growth, driven by advancements in nanotechnology that enhance specificity, sensitivity, and rapid on-site disease diagnosis. New point-of-care assays for CRP testing are emerging, responding to the increasing demand for swift diagnostic tools. Research from Mohammed VI University highlights CRP's potential in assessing SARS-CoV-2 severity, further cementing its relevance. Additionally, the rising prevalence of inflammatory disorders, diabetes, and cancers, alongside a growing incidence of endometriosis and increased funding in diagnostics, is expected to fuel market expansion. Notably, the CDC reported that over 20.1 million adults in the U.S. suffer from coronary artery disease, a number anticipated to rise, thereby amplifying market opportunities in this sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global C-Reactive Protein Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global C-Reactive Protein Testing Market Segmental Analysis

Global C-Reactive Protein Testing Market is segmented by assay type, detection range, disease area, end-use and region. Based on assay type, the market is segmented into immunoturbidimetric assay, ELISA, chemiluminescence immunoassay and others. Based on detection range, the market is segmented into HS-CRP, conventional CRP and cCRP. Based on disease area, the market is segmented into cardiovascular diseases, cancer, rheumatoid arthritis, inflammatory bowel disease, endometriosis, lupus and others. Based on end-use, the market is segmented into clinics, hospitals, laboratories, assisted living healthcare facilities, home and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global C-Reactive Protein Testing Market

The global C-reactive protein testing market is poised for significant growth, primarily fueled by the increasing prevalence of cardiovascular diseases. With over 800,000 fatalities attributed to cardiovascular conditions annually in the United States alone, the demand for effective C-reactive protein testing methods is surging. Additionally, the ongoing research and development aimed at enhancing these testing methodologies will further propel market expansion. The combination of an ageing population and a rising incidence of diabetes mellitus also contributes to this upward trend, indicating a robust market potential in the foreseeable future as healthcare providers seek better diagnostic solutions.

Restraints in the Global C-Reactive Protein Testing Market

The global C-Reactive Protein Testing market is likely to face significant restraints primarily due to low awareness about CRP testing and the limited availability of advanced technologies in lower and medium-sized economies worldwide. This lack of knowledge can lead to underutilization of these important diagnostic tools, hindering market expansion. Furthermore, the high costs associated with CRP testing procedures and the substantial initial investments required to establish appropriate setups could further inhibit growth in the market. Together, these factors pose considerable challenges that may slow down the adoption and proliferation of C-reactive protein testing solutions globally during the forecast period.

Market Trends of the Global C-Reactive Protein Testing Market

The global C-Reactive Protein (CRP) testing market is experiencing significant growth, driven by heightened awareness programs and government initiatives aimed at educating the public on chronic disease prevention and treatment. This surge in awareness has led to the widespread integration of CRP testing in routine clinical practices, particularly in developed regions such as the United States, Germany, France, and Japan. As healthcare providers increasingly prioritize CRP tests for assessing inflammation and guiding treatment decisions, the market is poised for robust expansion in the coming years, reflecting a shift towards proactive health management and early disease detection.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2023
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Study Analysis

Global C-Reactive Protein Testing Market Size by Assay Type & CAGR (2024-2031)

Market Overview
Immunoturbidimetric Assay
Elisa
- Clinical
- Non-Clinical
Chemiluminescence Immunoassay
Others

Global C-Reactive Protein Testing Market Size by Detection Range & CAGR (2024-2031)

Market Overview
HS-CRP
Conventional CRP
CCRP

Global C-Reactive Protein Testing Market Size by Disease Area & CAGR (2024-2031)

Market Overview
Cardiovascular Diseases
Cancer
Rheumatoid Arthritis
Inflammatory Bowel Disease
Endometriosis
Lupus
Others

Global C-Reactive Protein Testing Market Size by End-Use & CAGR (2024-2031)

Market Overview
Clinics
- By Entity
- Physician Offices
- Small Clinics
- Others
- By Settings
- Urban Setting
- Rural Setting
Hospitals
- Urban Setting
- Rural Setting
Laboratories
- Urban Setting
- Rural Setting
Assisted Living Healthcare Facilities
- Urban Setting
- Rural Setting
Home
Others

Global C-Reactive Protein Testing Market Size & CAGR (2024-2031)

North America (Assay Type, Detection Range, Disease Area, End-Use)
- US
- Canada
Europe (Assay Type, Detection Range, Disease Area, End-Use)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Assay Type, Detection Range, Disease Area, End-Use)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Assay Type, Detection Range, Disease Area, End-Use)
- Brazil
- Rest of Latin America
Middle East & Africa (Assay Type, Detection Range, Disease Area, End-Use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2023
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Thermo Fisher Scientific Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Beckman Coulter
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthcare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quest Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ortho Clinical Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Randox Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boditech Med Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck Millipore
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioMerieux
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Trinity Biotech
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (BD)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sekisui Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tosoh Bioscience Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DiaSorin S.p.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fujifilm Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments